# A Study to Learn About Heart-Related Risks in Elderly Men With Advanced Prostate Cancer Treated With Enzalutamide or Darolutamide

> **NCT07672119** · — · RECRUITING · sponsor: **Bayer** · enrollment: 3000 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT07672119
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-04
- **Primary completion:** 2027-04-29
- **Final completion:** 2027-04-29
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2026-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07672119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07672119, "A Study to Learn About Heart-Related Risks in Elderly Men With Advanced Prostate Cancer Treated With Enzalutamide or Darolutamide". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07672119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*